Lipid polymer hybrid nanoparticles (LPHN) are novel systems which are potentially
emerging in the era of nano-medicine. They are core-shell nanostructures which comprise of …

Surface-functionalized nanostructures are at the forefront of biotechnology, providing new
opportunities for biosensors, drug delivery, therapy, and bioimaging applications. The …

The blood-brain barrier (BBB) and the blood-cerebrospinal fluid barrier (BCSF) are two of
the most complex and sophisticated concierges that defend the central nervous system …

Polysaccharides, due to their remarkable features, have gained significant prominence in
the sustainable production of nanoparticles (NPs). High market demand and minimal …

Lipid nanoparticles (LNPs) are spherical vesicles composed of ionizable lipids that are
neutral at physiological pH. Despite their benefits, unmodified LNP drug delivery systems …

The disorder of Alzheimer's is marked by progressive pathophysiological
neurodegeneration. The amino acid peptides in the amyloid plaques found in the brains of …

Glioblastoma is one of the most difficult to treat cancers with poor prognosis and survival of
around one year from diagnosis. Effective treatments are desperately needed. This work …

Growing demand for highly effective, site-specific delivery of pharmaceuticals and
nutraceuticals using nano-sized carriers has prompted increased scrutiny of carrier …

Central nervous system (CNS) diseases, ranging from brain cancers to neurodegenerative
disorders like dementia and acute conditions such as strokes, have been heavily burdening …

Nanoparticles have a great potential to significantly improve the delivery of therapeutics to
the brain and may also be equipped with properties to investigate brain function. The brain …